Department of Ophthalmology, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA.
J Clin Invest. 2010 Sep;120(9):3022-32. doi: 10.1172/JCI42142. Epub 2010 Sep 1.
Retinopathy of prematurity (ROP) is a major complication of preterm birth. It encompasses a spectrum of pathologies that affect vision, from mild disease that resolves spontaneously to severe disease that causes retinal detachment and subsequent blindness. The pathologies are characterized by an arrest in normal retinal vascular development associated with microvascular degeneration. The resulting ischemia and retinal hypoxia lead to excessive abnormal compensatory blood vessel growth. However, this neovascularization can lead to fibrous scar formation and culminate in retinal detachment. Present therapeutic modalities to limit the adverse consequences of aberrant neovascularization are invasive and/or tissue-destructive. In this Review, we discuss current concepts on retinal microvascular degeneration, neovascularization, and available treatments, as well as present future perspectives toward more profound elucidation of the pathogenesis of ROP.
早产儿视网膜病变(ROP)是早产儿的主要并发症。它包含了一系列影响视力的病理学变化,从轻到重不等,从可以自发消退的轻度疾病到导致视网膜脱离和随后失明的严重疾病。这些病理学变化的特征是正常视网膜血管发育的停滞,伴有微血管退化。由此产生的缺血和视网膜缺氧导致过度异常的代偿性血管生长。然而,这种新生血管形成可能导致纤维瘢痕形成,并最终导致视网膜脱离。目前,限制异常新生血管不良后果的治疗方法具有侵入性和/或组织破坏性。在这篇综述中,我们讨论了视网膜微血管退化、新生血管形成和现有治疗方法的当前概念,以及未来更深入阐明 ROP 发病机制的前景。